These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36827734)

  • 1. A modified bonded model approach for molecular dynamics simulations of New Delhi Metallo-β-lactamase.
    Eshtiwi AA; Rathbone DL
    J Mol Graph Model; 2023 Jun; 121():108431. PubMed ID: 36827734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
    Muteeb G; Alsultan A; Farhan M; Aatif M
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refined models of New Delhi metallo-beta-lactamase-1 with inhibitors: an QM/MM modeling study.
    Wang YT; Cheng TL
    J Biomol Struct Dyn; 2016 Oct; 34(10):2214-23. PubMed ID: 26488313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiscale approach to predict the binding mode of metallo beta-lactamase inhibitors.
    Gervasoni S; Spencer J; Hinchliffe P; Pedretti A; Vairoletti F; Mahler G; Mulholland AJ
    Proteins; 2022 Feb; 90(2):372-384. PubMed ID: 34455628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor and substrate binding by New Delhi metallo-beta-lactamase-1: a molecular dynamics studies.
    Wang YT; Lu CY; Hour TC; Cheng TL
    Curr Comput Aided Drug Des; 2014; 10(3):197-204. PubMed ID: 25479381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
    Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
    Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
    Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1).
    Shen B; Yu Y; Chen H; Cao X; Lao X; Fang Y; Shi Y; Chen J; Zheng H
    PLoS One; 2013; 8(5):e62955. PubMed ID: 23675445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in passive residues modulate 3D-structure of NDM (New Delhi metallo-β-lactamase) protein that endue in drug resistance: a MD simulation approach.
    Kumar R
    J Biomol Struct Dyn; 2022; 40(19):9492-9508. PubMed ID: 34034624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods.
    Salari-Jazi A; Mahnam K; Sadeghi P; Damavandi MS; Faghri J
    Sci Rep; 2021 Jan; 11(1):2390. PubMed ID: 33504907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A close look onto structural models and primary ligands of metallo-β-lactamases.
    Raczynska JE; Shabalin IG; Minor W; Wlodawer A; Jaskolski M
    Drug Resist Updat; 2018 Sep; 40():1-12. PubMed ID: 30466711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulation studies of novel β-lactamase inhibitor.
    Ul Haq F; Abro A; Raza S; Liedl KR; Azam SS
    J Mol Graph Model; 2017 Jun; 74():143-152. PubMed ID: 28432959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
    Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H
    Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Lysine-Targeted Affinity Label for Serine-β-Lactamase Also Covalently Modifies New Delhi Metallo-β-lactamase-1 (NDM-1).
    Thomas PW; Cammarata M; Brodbelt JS; Monzingo AF; Pratt RF; Fast W
    Biochemistry; 2019 Jun; 58(25):2834-2843. PubMed ID: 31145588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Inhibitory Compounds for Metallo-β-lactamases and Structural Analysis of the Binding Modes.
    Kamo T; Kuroda K; Kondo S; Hayashi U; Fudo S; Yoneda T; Takaya A; Nukaga M; Hoshino T
    Chem Pharm Bull (Tokyo); 2021; 69(12):1179-1183. PubMed ID: 34853284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural studies on New Delhi Metallo-β-lactamase (NDM-2) suggest old β-lactam, penicillin to be better antibiotic for NDM-2-harbouring Acinetobacter baumanni.
    Tiwari V; Moganty RR
    J Biomol Struct Dyn; 2013; 31(6):591-601. PubMed ID: 22888760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Potential Inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) Using In Silico and In Vitro Approaches.
    Muteeb G; Rehman MT; AlAjmi MF; Aatif M; Farhan M; Shafi S
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144666
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Rahman M; Khan MKA
    J Biomol Struct Dyn; 2020 Apr; 38(7):2093-2103. PubMed ID: 31184285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and
    Moreira JS; Galvão DS; Xavier CFC; Cunha S; Pita SSDR; Reis JN; Freitas HF
    J Biomol Struct Dyn; 2022; 40(24):14223-14235. PubMed ID: 34766882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
    Linciano P; Cendron L; Gianquinto E; Spyrakis F; Tondi D
    ACS Infect Dis; 2019 Jan; 5(1):9-34. PubMed ID: 30421910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.